FDA Drug Shortages

$179 / year

Food and Drug Administration (FDA) Drug Shortages includes information about current drugs in shortage and resolved shortages of specific drug products, resource information, and relevant links.

Complexity

Food and Drug Administration (FDA) Drug Shortages includes information about current drugs in shortage and resolved shortages of specific drug products including date first posted, updated date, therapeutic category, estimated shortage duration, resource information and relevant links.

Date Created

2011-02

Last Modified

2020-07-24

Version

2020-07-24

Update Frequency

Monthly

Temporal Coverage

N/A

Spatial Coverage

United States

Source

John Snow Labs; U.S. Food and Drug Administration (FDA);

Source License URL

Source License Requirements

N/A

Source Citation

N/A

Keywords

FDA Drug Shortages, Drug Shortages, FDA Drug Database, FDA Drugs, Current Drug Shortages

Other Titles

Current and Resolved Drug Shortages, Current and Resolved Shortages Listed by Generic Name or Active Ingredient

NameDescriptionTypeConstraints
Generic_Name_or_Active_IngredientProduct Namestringrequired : 1
StatusCurrent_Status_of_the_productstringenum : Array required : 1
Date_First_PostedDate first postedstring-
Date_ResolvedDate resolveddate-
Therapeutic_CategoriesTherapeutic Categories to productsstring-
Company_NameLaboratory (MA Holder)stringrequired : 1
Last_UpdateLast status update datedate-
Company_Contact_InformationCompany Contact Informationstring-
PresentationPresentation of products including NDCstring-
Availability_and_Estimated_Shortage_DurationAvailability and Estimated Shortage Durationstring-
Related_InformationRelated Information about shortagestring-
Shortage_ReasonShortage Reason (per Food and Drug Administration Safety and Innovation Act)string-
Generic Name or Active IngredientStatusDate First PostedDate ResolvedTherapeutic CategoriesCompany NameLast UpdateCompany Contact InformationPresentationAvailability and Estimated Shortage DurationRelated InformationShortage Reason
Abciximab (ReoPro) InjectionTo be Discontinued2018-04-112019-08-15CardiovascularJanssen Biotech, Inc.2019-08-15800-586-77362mg/mL (NDC 57894-200-01)Janssen has made a business decision to discontinue manufacture of the drug product.
Abiraterone Acetate TabletsTo be Discontinued2020-06-052020-06-05OncologyJanssen Research and Development, LLC2020-06-05800-526-7736250 mg tablets (NDC 57894-155-12)
Acarbose (Precose) TabletsTo be Discontinued2019-02-012019-02-01Endocrinology/MetabolismBayer2019-02-01888-842-2937Bottles of 100 Tablets 25 mg (NDC 50419-863-51)Business decision to discontinue marketing in the US.
Acarbose (Precose) TabletsTo be Discontinued2019-02-012019-02-01Endocrinology/MetabolismBayer2019-02-01888-842-2937Bottles of 100 Tablets 50 mg (NDC 50419-861-51)Business decision to discontinue marketing in the US.
Acarbose (Precose) TabletsTo be Discontinued2019-02-012019-02-01Endocrinology/MetabolismBayer2019-02-01888-842-2937Bottles of 100 Tablets 100 mg (NDC 50419-862-51)Business decision to discontinue marketing in the US.
Acarbose (Precose) TabletsTo be Discontinued2019-02-012019-02-01Endocrinology/MetabolismBayer2019-02-01888-842-2937Unit Dose 50 mg (NDC 50419-861-48)Business decision to discontinue marketing in the US.
Acetaminophen/Tramadol Hydrochloride (Ultracet) TabletsTo be Discontinued2020-04-012020-04-01Analgesia/AddictionJanssen Pharmaceuticals2020-04-01800-526-7736325 mg/1 unit || 37.5 mg/1 unit (NDC 50458-650-60)The Company has made a business decision to permanently discontinue Ultracet. Product should be maintained on the formularies until the last batch produced expires (31 Oct 2022), in order to maintain continuity of the reimbursement process.
Acrivastine and Pseudoephedrine Hydrochloride CapsulesTo be Discontinued2020-06-022020-06-02Pulmonary/AllergyEndo Pharmaceuticals, Inc.2020-06-02800-462-3636Semprex-D Capsules, 8 mg/ 60mg , 100 capsules, (NDC 52244-404-10)Endo has made a business decision to permanently discontinue the drug product.
Acyclovir Capsules, USPTo be Discontinued2019-03-212019-03-21AntiviralTeva Pharmaceuticals2019-03-21800-545-8800200 mg, 100 count (NDC 0093-8940-01)Teva made a business decision to discontinue product.
Acyclovir Capsules, USPTo be Discontinued2019-03-212019-03-21AntiviralTeva Pharmaceuticals2019-03-21800-545-8800200 mg, 500 count (NDC 0093-8940-05)Teva made a business decision to discontinue product.